Meyers Associates, LP and SignPath Pharma, Inc.
We are currently investigating allegations made against Meyers Associates LP, a New York City-based securities brokerage firm. FINRA (the Financial Industry Regulatory Authority) brought a regulatory action against Meyers Associates, making numerous allegations regarding its conduct, including (among other allegations): a) that it sent misleading and unbalanced advertising materials with regard to its sale of SignPath Pharma, Inc.,; b) that it failed to maintain an adequate supervisory system to review emails; and c) that it failed to report customer complaints.
FINRA alleged that Meyers Associates sold SignPath Pharma, a private placement, to customers during 2011. FINRA also made allegations against Meyers Associates’ owner and principal, Bruce Meyers. After a hearing, it was found that Meyers Associates violated several FINRA rules and ordered it to pay a $700,000 fine. Bruce Meyers was also ordered to pay a $75,000 fine and was permanently barred from acting in a supervisory or principal capacity. Claims against another executive of the firm, Imtiaz Khan, were dismissed.
Israels & Neuman PLC is a securities and investment fraud law firm with offices in Denver, Colorado and the Seattle area. We represent investors in FINRA arbitration proceedings in all 50 states, including investors in New York. Our attorneys have represented over one thousand investors against many brokerage firms in the past, including Legend Securities, LPL Financial, Merrill Lynch, Morgan Stanley, Smith Barney, Stifel Nicolaus & Company, UBS Financial Services, Oppenheimer, Charles Schwab, Wells Fargo Advisors, Ameriprise Financial Services, Raymond James, ProEquities, Securities America, National Securities Corp., and many others.
Click to view: Meyers Associates FINRA Order